Surgical staging of cancer: Impact on prognosis and potential for bias in clinical trials

Current Oncology Reports

Volumn 5, Issue 6, 2003, Pages 437-438

  Markman, Maurie ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MELPHALAN; PLATINUM; ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DATA ANALYSIS; EDITORIAL; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; OUTCOMES RESEARCH; OVARY CANCER; PATIENT CARE; PROGNOSIS; SECOND LOOK SURGERY; DISEASE MANAGEMENT; NEOPLASM; PATHOLOGY; RISK FACTOR; SURGERY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CLINICAL TRIALS; DISEASE MANAGEMENT; HUMANS; MELPHALAN; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 2442493015     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-003-0001-2     Document Type: Editorial

References (12)

1. Young RC, Decker DG, Wharton JT, et al.: Staging laparotomy in early ovarian cancer. JAMA 1983, 250:3072-3076.
2. International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003, 95:125-132.
3. Trimbos JB, Vergote I, Bolis G, et al.: Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer - Adjuvant Chemotherapy in Ovarian Neoplasm Trial. J Natl Cancer Inst 2003, 95:113-125.
4. International Collaborative Ovarian Neoplasm 1 (ICON1) and European Organisation for Research and Treatment of Cancer Collaborators: Adjuvant Chemotherapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003, 95:105-112.
5. Young RC, Walton LA, Ellenberg SS, et al.: Adjuvant therapy in stage I and stage II epithelial ovarian cancer: results of two prospective randomized trials. N Engl J Med 1990, 322:1021-1027.
6. Gajra A, Newman N, Gamble GP, et al.: Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003, 21:1029-1034.
7. Sigurdson ER: Lymph node dissection: Is it diagnostic or therapeutic? J Clin Oncol 2003, 21:965-967.
8. Cain JM, Saigo PE, Pierce VK, et al.: A review of second-look laparotomy for ovarian cancer. Gynecol Oncol 1986, 23:14-25.
9. Smirz LR, Stehman FB, Ulbright TM, et al.: Second-look laparotomy after chemotherapy in the management of ovarian malignancy. Am J Obstet Gynecol 1985, 152:661-668.
10. Friedman JB, Weiss NS: Second thoughts about second-look laparotomy in advanced ovarian cancer. N Engl J Med 1990, 322:1079-1081.
11. Advanced Ovarian Cancer Trialists' Group: Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Br J Cancer 1998, 78:1479-1487.
12. Cannistra SA: Cancer of the ovary. N Engl J Med 1993, 329:1550-1559.